5275
Clinical Trials in IBD: Small Molecules and Monitoring Strategies
Date
May 6, 2025
Explore related products in the following collection:
Society: AGA
This session will examine monitoring strategies for dysplasia detection in IBD, treatment targets in the VERDICT trial, and compare small molecule therapy to steroids or biologic in IBD.
This session will examine monitoring strategies for dysplasia detection in IBD, treatment targets in the VERDICT trial, and compare small molecule therapy to steroids or biologic in IBD.
Moderators
Icahn School of Medicine at Mount Sinai
Western University
